Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 96 | 2023 | 3213 | 6.390 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 18 | 2017 | 550 | 2.590 |
Why?
|
Fatigue | 8 | 2021 | 1549 | 2.220 |
Why?
|
Brain | 101 | 2024 | 27171 | 2.110 |
Why?
|
Magnetic Resonance Imaging | 154 | 2024 | 36532 | 2.060 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 11 | 2023 | 253 | 1.780 |
Why?
|
Atrophy | 31 | 2020 | 1635 | 1.550 |
Why?
|
Nerve Fibers, Myelinated | 11 | 2011 | 952 | 1.280 |
Why?
|
Subtraction Technique | 4 | 2011 | 512 | 0.820 |
Why?
|
Disease Progression | 31 | 2022 | 13632 | 0.800 |
Why?
|
Leukoencephalopathies | 5 | 2019 | 259 | 0.780 |
Why?
|
Medial Forebrain Bundle | 1 | 2021 | 42 | 0.720 |
Why?
|
Imaging, Three-Dimensional | 13 | 2018 | 4034 | 0.690 |
Why?
|
Cognition Disorders | 14 | 2015 | 3967 | 0.690 |
Why?
|
Anti-Anxiety Agents | 1 | 2023 | 402 | 0.690 |
Why?
|
Image Interpretation, Computer-Assisted | 15 | 2019 | 3356 | 0.680 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 6 | 2019 | 254 | 0.640 |
Why?
|
Image Processing, Computer-Assisted | 30 | 2018 | 8923 | 0.640 |
Why?
|
Thalamus | 6 | 2024 | 1048 | 0.540 |
Why?
|
Neurofilament Proteins | 4 | 2022 | 337 | 0.510 |
Why?
|
Image Enhancement | 13 | 2020 | 2858 | 0.510 |
Why?
|
Gait | 7 | 2011 | 820 | 0.510 |
Why?
|
Aging | 15 | 2021 | 8731 | 0.490 |
Why?
|
Cerebrovascular Disorders | 4 | 2013 | 1470 | 0.480 |
Why?
|
Mobility Limitation | 4 | 2013 | 408 | 0.440 |
Why?
|
Longitudinal Studies | 29 | 2020 | 14751 | 0.430 |
Why?
|
Spinal Cord | 6 | 2020 | 1784 | 0.430 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2021 | 2798 | 0.410 |
Why?
|
Reproducibility of Results | 29 | 2023 | 20124 | 0.410 |
Why?
|
Corpus Callosum | 6 | 2018 | 751 | 0.400 |
Why?
|
Male | 137 | 2023 | 363698 | 0.390 |
Why?
|
Gait Disorders, Neurologic | 2 | 2011 | 246 | 0.380 |
Why?
|
Meningeal Neoplasms | 1 | 2020 | 1252 | 0.380 |
Why?
|
Physicians' Offices | 1 | 2011 | 60 | 0.370 |
Why?
|
Diffusion Tensor Imaging | 10 | 2018 | 2410 | 0.370 |
Why?
|
Humans | 188 | 2024 | 765968 | 0.370 |
Why?
|
Neuropsychological Tests | 18 | 2016 | 7123 | 0.360 |
Why?
|
Nerve Regeneration | 2 | 2007 | 802 | 0.360 |
Why?
|
Adult | 98 | 2023 | 223044 | 0.360 |
Why?
|
Blood Pressure | 7 | 2019 | 8532 | 0.350 |
Why?
|
Movement Disorders | 3 | 2005 | 461 | 0.350 |
Why?
|
Female | 127 | 2023 | 396112 | 0.340 |
Why?
|
Algorithms | 20 | 2021 | 14071 | 0.330 |
Why?
|
Pattern Recognition, Automated | 4 | 2015 | 978 | 0.330 |
Why?
|
Middle Aged | 82 | 2023 | 223009 | 0.330 |
Why?
|
Interferon-beta | 4 | 2014 | 346 | 0.320 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2009 | 139 | 0.320 |
Why?
|
Internet | 1 | 2020 | 3106 | 0.300 |
Why?
|
Anisotropy | 5 | 2021 | 1282 | 0.300 |
Why?
|
Delirium | 5 | 2019 | 1707 | 0.300 |
Why?
|
Corpus Striatum | 1 | 2014 | 1218 | 0.300 |
Why?
|
Anatomy, Artistic | 1 | 2008 | 50 | 0.300 |
Why?
|
Mathematical Computing | 2 | 2006 | 143 | 0.290 |
Why?
|
Disability Evaluation | 13 | 2013 | 1820 | 0.290 |
Why?
|
Medical Illustration | 1 | 2008 | 134 | 0.280 |
Why?
|
Walking | 3 | 2011 | 1198 | 0.280 |
Why?
|
Gadolinium | 7 | 2020 | 965 | 0.280 |
Why?
|
Medulla Oblongata | 1 | 2008 | 246 | 0.270 |
Why?
|
Sensitivity and Specificity | 18 | 2017 | 14652 | 0.270 |
Why?
|
Glial Fibrillary Acidic Protein | 3 | 2023 | 564 | 0.260 |
Why?
|
Cardiac Output | 1 | 2009 | 840 | 0.260 |
Why?
|
HLA Antigens | 2 | 2010 | 1339 | 0.260 |
Why?
|
Gadolinium DTPA | 4 | 2007 | 823 | 0.250 |
Why?
|
Depression | 4 | 2021 | 8237 | 0.250 |
Why?
|
Artifacts | 8 | 2008 | 1893 | 0.250 |
Why?
|
Information Management | 1 | 2005 | 100 | 0.230 |
Why?
|
Seasons | 1 | 2010 | 1524 | 0.230 |
Why?
|
Macaca mulatta | 2 | 2008 | 2341 | 0.230 |
Why?
|
Statistics as Topic | 3 | 2009 | 2352 | 0.220 |
Why?
|
Hypoxia, Brain | 1 | 2004 | 139 | 0.220 |
Why?
|
Friedreich Ataxia | 2 | 2013 | 82 | 0.200 |
Why?
|
Severity of Illness Index | 18 | 2020 | 15880 | 0.190 |
Why?
|
Anxiety | 1 | 2017 | 4671 | 0.190 |
Why?
|
Nerve Degeneration | 1 | 2006 | 748 | 0.190 |
Why?
|
Prospective Studies | 23 | 2023 | 54802 | 0.190 |
Why?
|
Essential Tremor | 1 | 2024 | 160 | 0.190 |
Why?
|
Cerebellum | 4 | 2018 | 1518 | 0.190 |
Why?
|
Brain Ischemia | 3 | 2016 | 3000 | 0.180 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 26318 | 0.180 |
Why?
|
Aged, 80 and over | 26 | 2019 | 59489 | 0.180 |
Why?
|
Models, Neurological | 3 | 2010 | 1747 | 0.180 |
Why?
|
Cerebrovascular Circulation | 5 | 2016 | 2674 | 0.180 |
Why?
|
Central Nervous System | 2 | 2006 | 1341 | 0.180 |
Why?
|
Cerebral Veins | 2 | 2016 | 157 | 0.170 |
Why?
|
Brain Mapping | 14 | 2016 | 6601 | 0.170 |
Why?
|
Spinal Cord Injuries | 1 | 2008 | 927 | 0.170 |
Why?
|
Aged | 39 | 2019 | 171117 | 0.170 |
Why?
|
Contrast Media | 7 | 2020 | 5329 | 0.170 |
Why?
|
Cognition | 10 | 2020 | 7049 | 0.170 |
Why?
|
Follow-Up Studies | 21 | 2019 | 39193 | 0.160 |
Why?
|
Immunologic Factors | 5 | 2013 | 1587 | 0.160 |
Why?
|
Memory, Short-Term | 3 | 2023 | 1003 | 0.150 |
Why?
|
Aquaporin 4 | 1 | 2019 | 161 | 0.150 |
Why?
|
Retinal Hemorrhage | 1 | 2018 | 98 | 0.140 |
Why?
|
Retinal Artery | 1 | 2018 | 109 | 0.140 |
Why?
|
Magnetic Resonance Angiography | 1 | 2004 | 1426 | 0.140 |
Why?
|
Speech | 1 | 2022 | 555 | 0.140 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2010 | 1896 | 0.140 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2023 | 492 | 0.140 |
Why?
|
Elasticity Imaging Techniques | 1 | 2022 | 398 | 0.140 |
Why?
|
Antihypertensive Agents | 2 | 2019 | 2033 | 0.140 |
Why?
|
Hypertension | 4 | 2019 | 8626 | 0.130 |
Why?
|
Wine | 1 | 2017 | 172 | 0.130 |
Why?
|
Echo-Planar Imaging | 5 | 2007 | 648 | 0.130 |
Why?
|
Optic Nerve | 1 | 2020 | 567 | 0.130 |
Why?
|
Alzheimer Disease | 7 | 2022 | 8730 | 0.130 |
Why?
|
Heart Diseases | 1 | 2009 | 2821 | 0.130 |
Why?
|
Retrospective Studies | 16 | 2023 | 81514 | 0.130 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2002 | 1456 | 0.120 |
Why?
|
Postoperative Complications | 5 | 2019 | 15747 | 0.120 |
Why?
|
Memory Disorders | 2 | 2016 | 1194 | 0.120 |
Why?
|
Confidentiality | 1 | 2019 | 607 | 0.120 |
Why?
|
Urinary Incontinence | 2 | 2010 | 491 | 0.120 |
Why?
|
Neuromyelitis Optica | 1 | 2019 | 266 | 0.120 |
Why?
|
Middle Cerebral Artery | 2 | 2013 | 268 | 0.120 |
Why?
|
Models, Theoretical | 2 | 2006 | 3564 | 0.120 |
Why?
|
Models, Biological | 2 | 2021 | 9443 | 0.110 |
Why?
|
Parietal Lobe | 3 | 2008 | 858 | 0.110 |
Why?
|
Nerve Fibers | 1 | 1998 | 705 | 0.110 |
Why?
|
Pyramidal Tracts | 1 | 2016 | 249 | 0.110 |
Why?
|
Cephalometry | 1 | 2016 | 380 | 0.110 |
Why?
|
Demyelinating Diseases | 1 | 2016 | 355 | 0.110 |
Why?
|
Artificial Intelligence | 4 | 2023 | 2659 | 0.110 |
Why?
|
Stereotaxic Techniques | 1 | 1996 | 551 | 0.110 |
Why?
|
Models, Statistical | 5 | 2015 | 5089 | 0.110 |
Why?
|
Regression Analysis | 8 | 2015 | 6322 | 0.110 |
Why?
|
Predictive Value of Tests | 12 | 2016 | 15398 | 0.110 |
Why?
|
Dementia | 1 | 2008 | 2744 | 0.100 |
Why?
|
Analysis of Variance | 4 | 2018 | 6203 | 0.100 |
Why?
|
Organ Size | 5 | 2017 | 2260 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 256 | 0.100 |
Why?
|
Mental Processes | 1 | 2013 | 243 | 0.100 |
Why?
|
Stroke | 3 | 2023 | 9747 | 0.100 |
Why?
|
HLA-B Antigens | 2 | 2010 | 329 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 6 | 2004 | 3672 | 0.100 |
Why?
|
Prognosis | 7 | 2016 | 29922 | 0.100 |
Why?
|
Theory of Mind | 1 | 2013 | 95 | 0.100 |
Why?
|
Young Adult | 17 | 2017 | 59889 | 0.100 |
Why?
|
Brain Diseases | 2 | 2018 | 1546 | 0.090 |
Why?
|
Thalamic Nuclei | 1 | 2012 | 113 | 0.090 |
Why?
|
Microvessels | 1 | 2016 | 591 | 0.090 |
Why?
|
Psychomotor Performance | 2 | 2013 | 1881 | 0.090 |
Why?
|
Skull | 1 | 2016 | 811 | 0.090 |
Why?
|
Software | 4 | 2018 | 4462 | 0.090 |
Why?
|
Drug Substitution | 1 | 2014 | 292 | 0.090 |
Why?
|
Executive Function | 3 | 2019 | 1391 | 0.090 |
Why?
|
Cohort Studies | 10 | 2019 | 41649 | 0.090 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 38 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 5 | 2013 | 18071 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 1640 | 0.090 |
Why?
|
Temporal Lobe | 2 | 2008 | 1714 | 0.090 |
Why?
|
Consensus | 2 | 2020 | 3202 | 0.090 |
Why?
|
Caudate Nucleus | 1 | 2012 | 387 | 0.090 |
Why?
|
Head | 1 | 1996 | 925 | 0.090 |
Why?
|
Normal Distribution | 2 | 2009 | 267 | 0.090 |
Why?
|
AIDS Dementia Complex | 1 | 2011 | 154 | 0.090 |
Why?
|
Reaction Time | 1 | 2016 | 2086 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2023 | 2598 | 0.080 |
Why?
|
Motor Activity | 2 | 2016 | 2704 | 0.080 |
Why?
|
User-Computer Interface | 2 | 2007 | 1405 | 0.080 |
Why?
|
Facial Expression | 1 | 2013 | 516 | 0.080 |
Why?
|
Cerebral Cortex | 5 | 2013 | 5767 | 0.080 |
Why?
|
Albuterol | 1 | 2010 | 211 | 0.080 |
Why?
|
HLA-DR Antigens | 1 | 2010 | 608 | 0.080 |
Why?
|
Erythropoietin | 1 | 2013 | 716 | 0.080 |
Why?
|
Hippocampus | 3 | 2016 | 3775 | 0.080 |
Why?
|
Double-Blind Method | 7 | 2013 | 12437 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2921 | 0.080 |
Why?
|
Demography | 2 | 2013 | 1641 | 0.080 |
Why?
|
Disabled Persons | 2 | 2013 | 1208 | 0.080 |
Why?
|
Risk Factors | 12 | 2019 | 74840 | 0.070 |
Why?
|
Peptides | 2 | 2010 | 4331 | 0.070 |
Why?
|
Fuzzy Logic | 1 | 2007 | 58 | 0.070 |
Why?
|
Poisson Distribution | 1 | 2009 | 508 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2012 | 4209 | 0.070 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2009 | 330 | 0.070 |
Why?
|
Reference Values | 5 | 2009 | 4908 | 0.070 |
Why?
|
Gene Frequency | 2 | 2010 | 3624 | 0.070 |
Why?
|
Radionuclide Imaging | 1 | 2011 | 1978 | 0.070 |
Why?
|
Blood-Brain Barrier | 4 | 2015 | 1037 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2009 | 1145 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2006 | 2570 | 0.070 |
Why?
|
Preoperative Care | 1 | 2016 | 2267 | 0.070 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2009 | 639 | 0.060 |
Why?
|
Verbal Learning | 2 | 2009 | 461 | 0.060 |
Why?
|
Computational Biology | 1 | 2018 | 3559 | 0.060 |
Why?
|
Recurrence | 4 | 2021 | 8501 | 0.060 |
Why?
|
Receptor, Bradykinin B1 | 1 | 2005 | 12 | 0.060 |
Why?
|
Recovery of Function | 1 | 2016 | 2966 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2013 | 5302 | 0.060 |
Why?
|
Time | 1 | 2007 | 550 | 0.060 |
Why?
|
Observer Variation | 3 | 2018 | 2615 | 0.060 |
Why?
|
Time Factors | 11 | 2020 | 40065 | 0.060 |
Why?
|
Vaccines, Subunit | 1 | 2005 | 158 | 0.060 |
Why?
|
Echocardiography, Doppler | 1 | 2009 | 899 | 0.060 |
Why?
|
Reference Standards | 1 | 2008 | 1013 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3956 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4040 | 0.060 |
Why?
|
Electromagnetic Fields | 1 | 2006 | 290 | 0.060 |
Why?
|
High-Intensity Focused Ultrasound Ablation | 1 | 2024 | 42 | 0.060 |
Why?
|
Statistics, Nonparametric | 4 | 2011 | 2844 | 0.060 |
Why?
|
Perfusion | 1 | 2009 | 1407 | 0.060 |
Why?
|
HIV | 1 | 2011 | 1585 | 0.060 |
Why?
|
Quality of Life | 2 | 2017 | 13462 | 0.050 |
Why?
|
Genetic Loci | 1 | 2013 | 2631 | 0.050 |
Why?
|
Calibration | 1 | 2006 | 814 | 0.050 |
Why?
|
Dominance, Cerebral | 1 | 2005 | 616 | 0.050 |
Why?
|
Adolescent | 14 | 2016 | 88835 | 0.050 |
Why?
|
Dyspnea | 1 | 2011 | 1352 | 0.050 |
Why?
|
beta-Lactams | 1 | 2005 | 158 | 0.050 |
Why?
|
Apolipoprotein E4 | 1 | 2008 | 708 | 0.050 |
Why?
|
Age Distribution | 1 | 2009 | 2858 | 0.050 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2005 | 239 | 0.050 |
Why?
|
Sirolimus | 1 | 2010 | 1545 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2013 | 2643 | 0.050 |
Why?
|
Alleles | 2 | 2010 | 6897 | 0.050 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2011 | 1899 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2023 | 171 | 0.050 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2005 | 339 | 0.050 |
Why?
|
Logistic Models | 6 | 2017 | 13266 | 0.050 |
Why?
|
Pilot Projects | 4 | 2022 | 8733 | 0.050 |
Why?
|
Information Dissemination | 2 | 2021 | 1142 | 0.050 |
Why?
|
Linear Models | 4 | 2018 | 5876 | 0.050 |
Why?
|
Medication Adherence | 1 | 2014 | 2192 | 0.050 |
Why?
|
Cerebral Arteries | 1 | 2004 | 490 | 0.050 |
Why?
|
Placebos | 2 | 2021 | 1659 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2011 | 2415 | 0.050 |
Why?
|
Smoking | 2 | 2009 | 9081 | 0.050 |
Why?
|
Age of Onset | 1 | 2009 | 3344 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2014 | 3475 | 0.050 |
Why?
|
Geriatric Assessment | 1 | 2009 | 1429 | 0.050 |
Why?
|
Auditory Cortex | 1 | 2005 | 364 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2010 | 2686 | 0.050 |
Why?
|
Monocytes | 2 | 2013 | 2595 | 0.050 |
Why?
|
Prevalence | 3 | 2019 | 15842 | 0.040 |
Why?
|
Treatment Outcome | 9 | 2019 | 65188 | 0.040 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2013 | 276 | 0.040 |
Why?
|
Immunoconjugates | 1 | 2008 | 981 | 0.040 |
Why?
|
Diffusion | 3 | 2015 | 808 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2880 | 0.040 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2008 | 886 | 0.040 |
Why?
|
Iron | 1 | 2009 | 1816 | 0.040 |
Why?
|
Adjuvants, Immunologic | 2 | 2010 | 995 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4528 | 0.040 |
Why?
|
Hydroxyquinolines | 1 | 1999 | 17 | 0.040 |
Why?
|
Hand | 1 | 2005 | 909 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7425 | 0.040 |
Why?
|
Computer Simulation | 3 | 2009 | 6255 | 0.040 |
Why?
|
Databases as Topic | 1 | 2021 | 471 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2006 | 2721 | 0.040 |
Why?
|
Neurons | 2 | 2022 | 9525 | 0.040 |
Why?
|
Incidence | 4 | 2023 | 21480 | 0.040 |
Why?
|
Plaque, Amyloid | 1 | 2022 | 772 | 0.040 |
Why?
|
Biological Assay | 1 | 2020 | 627 | 0.030 |
Why?
|
Hemoglobin SC Disease | 1 | 1996 | 23 | 0.030 |
Why?
|
Erythrocytes | 2 | 1996 | 2395 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1999 | 591 | 0.030 |
Why?
|
Bone Marrow | 2 | 1999 | 2921 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 2 | 2006 | 1811 | 0.030 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3432 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3247 | 0.030 |
Why?
|
Laser Therapy | 2 | 1993 | 1108 | 0.030 |
Why?
|
Motor Cortex | 2 | 2003 | 1003 | 0.030 |
Why?
|
Acoustic Stimulation | 3 | 2005 | 1255 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2016 | 102 | 0.030 |
Why?
|
Phenotype | 3 | 2013 | 16721 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1999 | 1132 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6309 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2005 | 1799 | 0.030 |
Why?
|
Hydroxyurea | 1 | 1996 | 284 | 0.030 |
Why?
|
Postural Balance | 1 | 2000 | 637 | 0.030 |
Why?
|
Pentetic Acid | 1 | 1995 | 208 | 0.030 |
Why?
|
Amygdala | 1 | 2003 | 1377 | 0.030 |
Why?
|
Anti-HIV Agents | 1 | 2011 | 4559 | 0.030 |
Why?
|
Meglumine | 1 | 1995 | 143 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1935 | 0.030 |
Why?
|
Electrodes | 1 | 1997 | 609 | 0.030 |
Why?
|
Age Factors | 4 | 2013 | 18380 | 0.030 |
Why?
|
Intracellular Membranes | 1 | 1995 | 386 | 0.030 |
Why?
|
HIV Infections | 2 | 2011 | 17533 | 0.030 |
Why?
|
Glioblastoma | 2 | 2019 | 3459 | 0.030 |
Why?
|
Phorbol Esters | 1 | 2013 | 108 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5696 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1885 | 0.030 |
Why?
|
Animals | 7 | 2022 | 168764 | 0.030 |
Why?
|
Face | 1 | 2019 | 1028 | 0.030 |
Why?
|
Epidemiologic Methods | 1 | 2018 | 1326 | 0.030 |
Why?
|
Morbidity | 1 | 2018 | 1749 | 0.030 |
Why?
|
Genotype | 3 | 2013 | 13024 | 0.030 |
Why?
|
Body Fluid Compartments | 1 | 1992 | 48 | 0.030 |
Why?
|
Oxygen | 4 | 2005 | 4241 | 0.030 |
Why?
|
Gene Expression | 1 | 2005 | 7584 | 0.020 |
Why?
|
Chemokine CXCL10 | 1 | 2013 | 310 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 1995 | 644 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2006 | 10261 | 0.020 |
Why?
|
Accidental Falls | 1 | 2019 | 1078 | 0.020 |
Why?
|
Receptors, Interleukin-2 | 2 | 2005 | 561 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3454 | 0.020 |
Why?
|
Comorbidity | 2 | 2019 | 10563 | 0.020 |
Why?
|
Interferon-gamma | 2 | 2010 | 3160 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6499 | 0.020 |
Why?
|
Brain Edema | 1 | 1995 | 602 | 0.020 |
Why?
|
Knee Joint | 2 | 1999 | 1656 | 0.020 |
Why?
|
Glutamine | 1 | 2013 | 576 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 305 | 0.020 |
Why?
|
Axons | 1 | 2018 | 1682 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1589 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2010 | 146 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2013 | 22223 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
Arginine | 1 | 2013 | 933 | 0.020 |
Why?
|
Sex Factors | 2 | 2007 | 10603 | 0.020 |
Why?
|
Child | 4 | 2013 | 80564 | 0.020 |
Why?
|
Cerebrospinal Fluid | 1 | 1992 | 539 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9550 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2000 | 5501 | 0.020 |
Why?
|
Drug Combinations | 1 | 1995 | 2077 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 30198 | 0.020 |
Why?
|
Adrenergic beta-Agonists | 1 | 2010 | 345 | 0.020 |
Why?
|
Lipids | 1 | 1999 | 3315 | 0.020 |
Why?
|
Interleukin-13 | 1 | 2010 | 388 | 0.020 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 418 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11206 | 0.020 |
Why?
|
Somatosensory Cortex | 2 | 2003 | 510 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2011 | 533 | 0.020 |
Why?
|
Urination | 1 | 2009 | 204 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2011 | 1478 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2011 | 1381 | 0.020 |
Why?
|
Occipital Lobe | 1 | 2009 | 376 | 0.020 |
Why?
|
Brain Infarction | 1 | 2009 | 285 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10729 | 0.020 |
Why?
|
Social Behavior | 1 | 2013 | 1146 | 0.020 |
Why?
|
Entorhinal Cortex | 1 | 2008 | 285 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2013 | 959 | 0.020 |
Why?
|
Third Ventricle | 1 | 2007 | 74 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2005 | 7478 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8875 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2011 | 1828 | 0.020 |
Why?
|
Attention | 1 | 2016 | 2419 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2011 | 4405 | 0.020 |
Why?
|
Complementarity Determining Regions | 1 | 2006 | 154 | 0.020 |
Why?
|
Immunologic Tests | 1 | 2006 | 101 | 0.020 |
Why?
|
Piperacillin | 1 | 2005 | 37 | 0.020 |
Why?
|
Ceftazidime | 1 | 2005 | 57 | 0.020 |
Why?
|
Central Nervous System Neoplasms | 1 | 1993 | 916 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2011 | 2587 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2012 | 1896 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 1994 | 1873 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18293 | 0.010 |
Why?
|
Differential Threshold | 1 | 2004 | 80 | 0.010 |
Why?
|
Area Under Curve | 1 | 2009 | 1638 | 0.010 |
Why?
|
Brain Neoplasms | 2 | 1998 | 9071 | 0.010 |
Why?
|
Thoracic Vertebrae | 1 | 2009 | 614 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2013 | 4260 | 0.010 |
Why?
|
Models, Structural | 1 | 2004 | 338 | 0.010 |
Why?
|
Genes, MHC Class II | 1 | 2005 | 433 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2007 | 912 | 0.010 |
Why?
|
Cephalosporins | 1 | 2005 | 200 | 0.010 |
Why?
|
Amoxicillin | 1 | 2005 | 180 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10383 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2741 | 0.010 |
Why?
|
Odds Ratio | 2 | 2010 | 9649 | 0.010 |
Why?
|
Markov Chains | 1 | 2007 | 968 | 0.010 |
Why?
|
Body Water | 2 | 1995 | 338 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 22332 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2006 | 657 | 0.010 |
Why?
|
Immune System | 1 | 2008 | 799 | 0.010 |
Why?
|
Mathematics | 1 | 2004 | 696 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2652 | 0.010 |
Why?
|
Gyrus Cinguli | 1 | 2009 | 1117 | 0.010 |
Why?
|
Cervical Vertebrae | 1 | 2009 | 974 | 0.010 |
Why?
|
RNA, Viral | 1 | 2011 | 2864 | 0.010 |
Why?
|
Rotation | 1 | 2004 | 513 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4850 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2011 | 1880 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 16047 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4348 | 0.010 |
Why?
|
Individuality | 1 | 2004 | 303 | 0.010 |
Why?
|
Clinical Competence | 1 | 2018 | 4863 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2007 | 834 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2007 | 2910 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2008 | 15652 | 0.010 |
Why?
|
Viral Load | 1 | 2011 | 3386 | 0.010 |
Why?
|
Educational Status | 1 | 2009 | 2513 | 0.010 |
Why?
|
Electroencephalography | 1 | 1997 | 6273 | 0.010 |
Why?
|
Dichotic Listening Tests | 1 | 2001 | 22 | 0.010 |
Why?
|
Cause of Death | 1 | 2011 | 3708 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7232 | 0.010 |
Why?
|
Hemodynamics | 1 | 2011 | 4184 | 0.010 |
Why?
|
Fingers | 1 | 2003 | 509 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3449 | 0.010 |
Why?
|
Phantoms, Imaging | 2 | 1999 | 2475 | 0.010 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2000 | 92 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1998 | 9373 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3685 | 0.010 |
Why?
|
Cues | 1 | 2005 | 877 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2011 | 2084 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20659 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8529 | 0.010 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2001 | 256 | 0.010 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2004 | 698 | 0.010 |
Why?
|
Radiography | 1 | 2010 | 6919 | 0.010 |
Why?
|
Memory | 1 | 2009 | 2190 | 0.010 |
Why?
|
Software Design | 1 | 1999 | 173 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9338 | 0.010 |
Why?
|
United States | 2 | 2018 | 72903 | 0.010 |
Why?
|
Spin Labels | 1 | 1999 | 334 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 1998 | 226 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4562 | 0.010 |
Why?
|
Glioma | 1 | 1993 | 3493 | 0.010 |
Why?
|
Erythrocyte Aggregation | 1 | 1996 | 35 | 0.010 |
Why?
|
Movement | 1 | 2003 | 1462 | 0.010 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 1 | 1996 | 150 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 12976 | 0.010 |
Why?
|
Arousal | 1 | 2001 | 1171 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 1996 | 201 | 0.010 |
Why?
|
Triethyltin Compounds | 1 | 1995 | 4 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11888 | 0.010 |
Why?
|
Ion Transport | 1 | 1996 | 322 | 0.010 |
Why?
|
Language | 1 | 2005 | 1550 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12056 | 0.010 |
Why?
|
Hydrogen | 1 | 1996 | 168 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2001 | 1870 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81819 | 0.010 |
Why?
|
Intraoperative Care | 1 | 1998 | 760 | 0.010 |
Why?
|
Hematocrit | 1 | 1996 | 621 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2001 | 1410 | 0.010 |
Why?
|
Child, Preschool | 2 | 2013 | 42500 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12509 | 0.010 |
Why?
|
Functional Laterality | 1 | 2001 | 2243 | 0.010 |
Why?
|
Extracellular Space | 1 | 1996 | 563 | 0.010 |
Why?
|
Fetal Hemoglobin | 1 | 1996 | 348 | 0.010 |
Why?
|
Water | 1 | 2000 | 1417 | 0.010 |
Why?
|
Chlorides | 1 | 1996 | 666 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1999 | 1731 | 0.010 |
Why?
|
PUVA Therapy | 1 | 1993 | 101 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2005 | 3850 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2005 | 5125 | 0.010 |
Why?
|
Lung | 1 | 2011 | 10033 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6209 | 0.010 |
Why?
|
Potassium | 1 | 1996 | 1311 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 3807 | 0.010 |
Why?
|
Triglycerides | 1 | 1999 | 2441 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1993 | 822 | 0.010 |
Why?
|
Hospitalization | 1 | 2011 | 10808 | 0.010 |
Why?
|
Laser Coagulation | 1 | 1993 | 334 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12807 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23601 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12768 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1996 | 3089 | 0.010 |
Why?
|
Hypothalamus | 1 | 1995 | 993 | 0.010 |
Why?
|
Forecasting | 1 | 1999 | 2936 | 0.010 |
Why?
|
Neural Pathways | 1 | 2001 | 3085 | 0.010 |
Why?
|
Hemoglobins | 1 | 1996 | 1530 | 0.010 |
Why?
|
Radiosurgery | 1 | 1998 | 1328 | 0.000 |
Why?
|
Rabbits | 1 | 1995 | 4734 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1997 | 6014 | 0.000 |
Why?
|
Bone Marrow Cells | 1 | 1994 | 2412 | 0.000 |
Why?
|
Fatty Acids | 1 | 1994 | 1806 | 0.000 |
Why?
|
Lipid Metabolism | 1 | 1994 | 1892 | 0.000 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 4427 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1999 | 8041 | 0.000 |
Why?
|
Rats | 1 | 1993 | 23707 | 0.000 |
Why?
|